Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of CRIS115 Liposomes in Healthy Adults
NCT07375498Phase 1Not yet recruiting
- Sponsor
- Cristália
- Start
- Aug 2026
- Primary completion
- Dec 2026
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 1, open-label trial of CRIS115 in Drug Overdose, sponsored by Cristália. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
CRIS115
03
Conditions
Drug Overdose
Beyond the preview
Go deeper on NCT07375498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07375498.